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Two Bacillus sp. strains (B29 and B27) isolated from soil in the South of Tunisia were tested for their 
abilities to produce antimicrobial compounds. Both strains showed antimicrobial activity against Gram-
positive and Gram-negative bacteria, yeasts and fungi. The produced compounds were extracted by 
using four different solvents. The hexane solvent allowed to obtain maximum of activity of the strain 
B29. The activity of the strain B27 was not elucidated by the four solvents used. Bio-autography results 
of B29 hexane extract revealed presence of different antibiotics and antifungal compounds with 
different Rf values of 0.3 and 0.76 for antifungal compounds and of 0.12, 0.14, 0.19 and 0.3 for 
antibacterial ones. Two active fractions were isolated from the culture broth of the strain B29 by semi-
preparative high performance liquid chromatography (HPLC). The partial sequencing of the 16S rDNA 
gene was used to identify the two Bacillus strains. They may be assigned to new Bacillus species. 
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INTRODUCTION 
 
An analysis of the number of pathogenic bacteria and 
fungi indicated that they become resistant to antibiotics in 
common use. These antibacterial and antifungal 
resistances are presently an urgent focus of research and 
new antibiotics are necessary to combat these patho-
gens. An investigation of the potential sources of this 
molecules indicated that over 60% of approved drugs are 
derived from natural compounds (Cragg et al., 1997; 
Newman et al., 2003). Many organisms, including micro-
organisms, plants and some animals, have the capability 
to synthesize bioactive natural products. These natural 
products constitute a library of compounds with a large 
and privileged structural diversity, showing a variety of 
biological  activities.  In  fact,  many  of  them  have  been  
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used for agricultural or pharmaceutical applications 
(Salas and Mendez, 2007). The search for new, safer, 
broad-spectrum antifungal antibiotic with greater potency 
has been progressing slowly (Gupte et al., 2002). In the 
course of screening for new antibiotics, several research 
studies are currently oriented towards isolation of new 
microorganism’s species from different soils and 
ecosystems (Mellouli et al., 2003; Errakhi et al., 2007). 
Within microorganisms, the Bacillus species are one of 
the largest source of bioactive natural products. Various 
studies have confirmed that Bacillus species have a wide 
range of antimicrobial activities since they are used as 
antifungal (Milner et al., 1995), antibacterial (Yilmaz et al., 
2006), antiviral (Steller et al., 1999), antiameobocytic 
(Galvez et al., 1994) and antimycoplasma agents 
(Peypoux et al., 1999). These are often complex second-
dary metabolites with great potential for biotechnological 
and biopharmaceutical applications.  A  well-known  class 
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of such compounds includes the lipopeptides surfactin 
(Cho et al., 2003), fengycin (Vanittanakom et al., 1986), 
and the iturin compounds (Cho et al., 2009), iturin A, B 
and C (Peypoux et al., 1978), mycosubtilins (peypoux et 
al., 1976), bacillomycins (Peypoux et al., 1984), 
plipastatin (Tsuge et al., 1996) and di- and tripeptides 
such as bacilysin (Walker and Abraham, 1970) are 
peptide antibiotics with potent antimicrobial activities. 
In fact, the list of novel microorganisms, especially 
Bacillus, and products found in microbiologically 
unexplored ecosystems around the world suggest that a 
careful exploration of other habitats might continue to be 
useful. South of Tunisia is an explored ecosystem and 
may be a source of new microorganisms producing new 
compounds. In the present work, we describe a preli-
minary characterization of two bacterial strains isolated 
from south of Tunisia and to assess their antimicrobial 
activity based on molecular methods as well as the 
production, the isolation and the partial characterization 
of their antibiotics. 
 
 
MATERIALS AND METHODS 
 
Microorganism’s strains 
 
Bacillus strains, denoted B27 and B29, were previously isolated 
from salt soil in the south of Tunisia and identified as Bacillus sp. 
These bacteria were routinely grown on nutrient agar (NA) medium 
at 30°C for further treatments. Escherichia coli CIP 102 400, 
Staphylococcus aureus CIP658, Saccharomyces cerevisiae ATCC 
9226, Mycobacterium phlei CIP105 389, Micrococcus loteus 
CIPA270, Pseudomonas aerugenosa CIP 100720, Mucor 
ramannianus NRLL 1829 (strain collection of Laboratoire de génie 
chimique, Toulouse) and Botrytis cinerea (strain isolated from 
leaves of vine plants) as indicator microorganisms for the biological 
assays. 
 
 
Antimicrobial activity 
 
The antimicrobial and antifungal activity of the isolates was 
determined by the plate diffusion method (Barakate et al., 2002; 
Errakhi et al., 2007) against Gram-positive bacteria (M. loteus, S. 
aureus, and M. phlei), Gram-negative bacteria (E. coli and P. 
aerugenosa), yeasts (S. cerevisiae), and filamentous fungi (M. 
ramannianus and B. cinerea). Isolates were grown on NA medium 
and two discs (6 mm in diameter) were cut and placed on Bennett 
medium (beef extract (Merck, Germany) 1 g/l; glucose (Merck) 10 
g/l; peptone (Merck) 2 g/l; yeast extract (Merck) 1 g/l and agar 
(Difco) 15 g/l; for bacteria) and potato dextrose agar (PDA) medium 
(for fungi and yeasts) which were seeded with appropriate test 
organism. Plates were first kept in a refrigerator (4°C) for at least 2 
h to allow the diffusion of any antibiotics produced, then incubated 
at 30°C. Inhibition zones were determined after 24 h for bacteria 
and yeast and after 48 h for fungi. 
 
 
Production of antimicrobial activity in various media 
 
Antimicrobial activity of the two Bacillus strains was evaluated on 4 
media that is  YMA  (peptone  0.3%,  yeast  extract  0.5%,  mannitol  
 
 
 
 
2.5% and agar 15 g/l), NA, PDA and Bennett (BT). The two bacteria 
were inoculated on plates of 90 mm diameter on each of this media 
and incubated at 30°C for 24 h. The activity against M. loteus, E. 
coli, P. aerugenosa, S. cerevisiae and M. ramannianus was 
recorded by the plate diffusion method. Three discs (10 mm in 
diameter), for each bacteria and each medium, were cut and placed 
on BT (for bacteria) and PDA (for fungi and yeast) which were 
seeded with appropriate test organisms. Plates were first kept in a 
refrigerator (4°C) for at least 2 h to allow the diffusion of antibiotics 
produced, then incubated at 30°C. Inhibition zones were 
determined after 24 h for bacteria and yeast and after 48 h for fungi. 
 
 
Kinetics of antimicrobial products of the Bacillus sp. strains in 
potato dextrose medium 
 
The two Bacillus strains were selected for their interesting anti-
fungal properties. Kinetics of antimicrobial products was assessed 
on potato dextrose broth (PDB) medium. The pH media was 
adjusted to 7.2 and 100 ml aliquots were dispensed into 1 l 
Erlenmeyer flasks. The inoculated flasks were put on a shaker (250 
rpm; 30°C). 2 ml of the liquid culture were centrifuged to remove 
most of the bacterial cells, the supernatant was passed through a 
sterile filter 0.20 µm membranes, and the resulting broth was used 
for antifungal activity determination. The activity against M. luteus, 
S. cerevisiae, M. ramannianus, and B. cinerea was regularly 
recorded each 2 h by the agar diffusion method (well technique; 
each well of 10 mm in diameter was filled with 50 µl of supernatant). 
Fungi, bacteria, and yeast spore suspensions were prepared by 
suspending loopfuls of hyphae and colonies from PDA slant 
incubated at 22°C (B. cinerea) and 30°C for the other organisms. 
The suspension was filtered with sterile cotton (for B. cinerea). A 
108 CFU/ml spore suspension was obtained through dilutions and 
counting with a hemaecytometer and adjusted to 105 CFU/ml by 
serial dilution. 4 ml of the spore suspension was suspended under 
the PDA plates, containing the wells with the supernatant. The Petri 
dishes were incubated for 4 h at 4°C to allow the diffusion of 
produced antimicrobial metabolites and then incubated at 30°C for 
24 to 48 h. The relative inhibition data is presented as the diameter 
of development inhibition around wells. 
 
 
Production, extraction and detection of antibiotics 
 
Each Bacillus strain was cultivated in PDB medium in four 500 ml 
Erlenmeyer flasks each containing 100 ml of medium. The cultures 
were incubated at 30°C for 3 days under constant agitation of 250 
rpm. The liquid culture was centrifuged for 20 min at 8000 g to 
remove the bacteria. The supernatant was shared in 4 equal 
volumes of 100 ml, and then each was extracted with 200 ml of 
organic solvent. A range of extraction solvents was screened for 
effectiveness, including n-hexane, dichloromethane, n-butanol and 
ethyl acetate. The organic extracts were evaporated to dryness 
using a Rotavapor (Laborota 4000). The resulting dry extracts were 
recuperated in 2 ml of methanol and subjected to biological assay 
(25 µl) (disk of 6 mm in diameter, Institut Pasteur) against M. luteus, 
S. cerevisiae, M. ramannianus, P. aerugenosa, and B. cinerea. The 
solvents which gave the highest inhibition diameter were then 
retained for the detection of antibiotics by bioautography. 
 
 
Purification and partial characterization of antifungal products 
of Bacillus sp. strains 
 
Preparative chromatography with silica gel plates (Merck Art. 5735, 
Kiesselgel 60F254) was used for the partial purification of 
antimicrobial   products. For   this,  20 µl of  n-hexane  extract  were  
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spotted onto 20 × 20 cm silica gel plates, and then developed with 
butanol-acetic acid-water (3:1:1). The developed thin layer 
chromatography (TLC) plates were air-dried overnight at 37°C to 
remove all traces of solvents. They were then placed in a plastic 
bioassay dish (23 × 23 × 2.2 cm3, Fisher Scientific Labosi) and 
overlaid with 100 ml of PDB medium (containing 7 g/l of agar) 
seeded with M. luteus or M. ramannianus. After the agar had set, 
the plate was incubated at 30°C. After 2 days, reddish brown-
colored fungal growth or opaque bacterial growth was visible. Clear 
areas due to inhibition of microorganism growth indicated the 
location of antibiotic compounds on the TLC plates. The retention 
factor (RF) of each spot was recorded. 
The liquid cultures of B27 and B29 strains at 30°C for three days 
were harvested to remove the biomass. The cell-free supernatant 
fluid was extracted with hexane for B29 and with ethyl acetate for 
B27. Antibiotics were purified by HPLC (Waters: controller 600, 
pump 600, dual  absorption detector 2487, Linear Recorder); 
Column C18 (250 × 7.8 mm UP ODS); mobile phase: Linear 
gradient of methanol-H2O from 0 to 100% for 40 min, Flow rate: 1.5 
ml/min, detection: UV at 220 nm. Different peaks were collected 
separately, concentrated and then tested against M. ramannianus 
and M. luteus. After purification, the antibiotics were subjected to 
spectroscopic studies. The absorption spectrum of active extracts in 
methanol were recorded in the UV region (180 to 500 nm) by using 
a UV-visible Prekin-Elmer (Lambda 20) spectrophotometer and 
compared with those of known antifungal antibiotics. 
 
 
Identification of bacteria 
 
DNA extraction  
 
Single isolated colonies of the two bacterial cultures were taken 
from agar plates and suspended in 500 µl of lysis buffer (400 mM 
Tris-HCl (pH 8.0), 60 mM EDTA (pH 8.0), 150 mM NaCl, 1% 
sodium dodecyl sulfate). The tube is then left at room temperature 
for 10 min. After adding 150 µl of potassium acetate (pH 4.8), the 
tube is vortexed briefly and spun at >10 000 g for 1 min. After 
transferring the supernatant to a new Eppendorf tube, an equal 
volume of isopropyl alcohol is added. The tube is mixed by 
inversion briefly, spun at >10 000 g for 2 min and the supernatant is 
discarded. The resultant DNA pellet is washed in 300 µl of 70% 
ethanol. After the pellet is spun at 10 000 rpm for 1 min, the 
supernatant is discarded. The DNA pellet is air dried and dissolved 
in 50 µl of sterile ultrapure water (Liu et al., 2000).  
 
 
PCR amplification 
 
PCR amplification of almost full length 16SrRNA gene was carried 
out with specific primers 27F (5’-AGAGTTTGATCCTGGCTCAG-3’) 
and 1492r (5’-GGTTACCTTGTTACGACTT-3’). A 50 µl reaction 
volume PCR was performed using about 100 ng of genomic DNA, 
10X Reaction buffer, 10 mM (each) deoxynucleoside triphosphates, 
25 mM MgCl2 and 0.5 U of DNA polymerase. The PCR was 
performed in an automated Gene Amp PCR System thermal cycler 
under the following conditions. The amplification conditions were as 
follows 98°C for 4 min (denaturation), 55°C for 1 min (annealing), 
72°C for 3 min (elongation) and 72°C for 10 min final elongation. 
Expected PCR product of around 1.5 Kb was checked by 
electrophoresis of 5 µl of the PCR product on 1% agarose gel in 1X 
TBE buffer and stained with ethium bromide 0.5 µg / ml. 
The PCR products obtained were submitted to GenomExpress 
for sequence determination. The same primers as above and an 
automated sequencer were used for this purpose. The analysis of 
sequences was done at NCBI server  
 
 
 
(http://www.ncbi.nlm.nih.gov/BLAST). All the analyzed sequences 
have been deposited in genbank. 
 
 
Phylogenetic analysis 
 
Phylogenetic and molecular evolutionary analyses were conducted 
using softwares included in MEGA version 3.0 (Kumar et al., 2004) 
package. The 16S rDNA sequence of B27 and B29 strains was 
aligned using the CLUSTAL W program (Thompson et al., 1994) 
against corresponding nucleotide sequences of representatives of 
the genus Bacillus retrieved from GenBank. Evolutionary distance 
matrices were generated as described by Jukes and Cantor (1969) 
and a phylogenetic tree was inferred by the Neighbor joining 
method (Saitou and Nei, 1987). Tree topologies were evaluated by 
bootstrap analysis (Felsenstein, 1985) based on 1000 resembling 
of the neighbor joining data set. 
 
 
RESULTS 
 
Antimicrobial activity 
 
In order to assess whether the two Bacillus strains 
isolated from the salt soil originating from south of Tunisia 
habitats may be a useful source for natural bioactive 
compounds, the antimicrobial activity of the isolates was 
determined (Table 1). The two isolates exhibited 
antibiotic activity towards the Gram-negative bacteria E. 
coli and P. aerugenosa, the Gram-positive bacteria M. 
luteus, the yeast S. cerevisiae and the filamentous fungi 
M. ramannianus and B. cinerea. The activity against the 
Gram-positive bacteria, S. aureus and M. phlei, was not 
recorded. 
 
 
Choice of media for production of antibiotic 
 
The antifungal and antimicrobial productions in various 
media are illustrated in Table 2. PDA was found to be the 
better medium in promoting the production of antifungal 
and antimicrobial compounds active against micro-
organisms tested and was there for retained for later 
studies.  
 
 
Kinetics of antimicrobial products of the Bacillus sp. 
strains in potato dextrose medium 
 
Bacillus sp. strains produce metabolites that display 
antifungal activity. The growth inhibition of the two fungi 
B. cinerea and M. ramannianus, the yeast S. cerevisiae 
and the bacteria M. luteus by the broth of steady-
statecell-free supernatants at different time of growth of 
the bacteria show the presence of halo of inhibition that 
began at the stationary phase of the growth of the two 
bacteria (Figures 1 and 2). The results of antagonism 
tests have revealed an important antimicrobial activity of 
the two Bacillus strains, especially against filamentous 
fungi. Indeed, their activity is very strong against  the  two
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Table 1. Antimicrobial activity of B27 and B29 Bacillus sp. strains against microorganisms 
tested. 
 
Microorganisms Diameter of inhibition (mm) 
B27 B29 
Gram-positive bacteria   
M. luteus CIPA270 24.25 (± 0.85) 25 (± 0) 
S. aureus CIP658 - - 
M. phlei CIP105 389 - - 
   
Gram-negative bacteria   
E. coli CIP102 400 20.5 (± 0.5) 21.75 (± 0.75) 
P. aerugenosa CIP 100720 20.5 (± 0.5) 21.25 (± 0.47) 
   
Yeasts   
S. cerevisiae ATCC 9226 22.5 (± 0.28) 24 (± 0.40) 
   
Filamentous fungi   
M. ramannianus NRLL 1829 17.25 (± 0.28) 19.25 (± 0.47) 
B. cinerea 21.75 (± 0.62) 24 (± 0.40) 
 
Values given are the mean of four samples (± standard error of the arithmetic mean); (-) were not 
inhibited by the strain. 
 
 
 
Table 2. Antimicrobial activity of B27 and B29 Bacillus sp. strains in various culture media. 
 
 
YMA  NA  PDA  BT 
B27 B29  B27 B29  B27 B29  B27 B29 
M. luteus CIPA270 32  ± 0.4 35  ± 0.3  30 ± 0 35 ± 0.3  45 ± 0.22 55 ± 0.13  35 ± 0.31 45 ± 0.4 
E. coli CIP102 400 12  ± 1.1 19  ± 0.7  12 ± 0.65 18 ± 0.8  13 ± 0.13 20 ± 0.4  12 ± 0.51 16 ± 0.12 
P. aerugenosa CIP 100720 15 ± 0.75 21 ± 0.1  15 ± 0.01 24 ± 0.21  30 ± 0.11 25 ± 0  22 ± 0 23 ± 0 
S. cerevisiae ATCC 9226 12 ± 0.4 16 ± 0  14 ± 0.43 16 ± 0  17 ± 0.21 17 ± 0.22  15 ± 0 16 ± 0.11 
M. ramannianus NRLL 1829 12 ± 1.1 17 ± 0.2  12 ± 1.0 12 ± 0.12  17 ± 0.22 23 ± 0.11  12 ± 0.13 22 ± 0.21 
 
Values given are the mean of four samples ±standard error of the arithmetic mean. 
 
 
 
species M. ramannianus and B. cinerea. Concerning the 
antibacterial activity, the two Bacillus are strongly active 
against M. luteus and S. cerevisiae. The kinetic of 
production of the antibiotics was realized on PDB 
medium. Antifungal and antibacterial activities appear 
after 14 h against M. ramannianus, 18 h against M. 
luteus, 20 h against B. cinerea and 28 h against S. 
cerevisiae for the B29 strain (Figure 1). While for B27, the 
antimicrobial activity has been recorded after 18 h of 
culture against M. ramannianus, M. luteus and B. cinerea 
and 24 h against S. cerevisiae. These activities increase 
immediately and remain more or less stable thereafter 
(Figure 2). 
 
 
Extraction of antimicrobial activities 
 
The results of the antimicrobial assays of the isolate  B29 
are shown in Figure 3. The bacterium B29 exhibited 
antibiotic activity towards M. Luteus, S. cerevisiae, M. 
ramannianus and B. cinerea. The activity against P. 
aeruginosa was absent. The different fractions obtained 
from B27 isolate culture did not show any antibiotic 
activity against all microorganisms tested. 
The highest activity was exhibited by the strain B29, 
with an inhibition zone of 25 mm against S. cerevisiae, 20 
mm against M. ramannianus and 15 mm against B. 
cinerea in the hexane fraction (Figure 3). This bacterium 
showed important inhibitory activities against bacteria. In 
fact, the ethyl acetate fraction induced an inhibition zone 
of 25 mm towards M. luteus colony compared to 30 mm 
noted with the butanol fraction. The hexane has been 
therefore chosen as extraction solvent for the Bacillus 
strain B29. Therefore, this fraction was retained for later 
studies. The B27 strain exhibited strong antifungal and 
antimicrobial activity against the  microorganisms  tested.  
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Figure 1. Time course of growth and antibiotics production of Bacillus sp. strain B29 on PDB medium at 30°C. The 
measure of the diameter inhibition against microorganisms was undertaken by the discs method (25 µL extract by disc). 
Values represent diameter inhibition in mm, including the discs diameter (6 mm). 
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Figure 2. Time course of growth and antibiotics production of Bacillus sp. strain B27 on PDB medium at 30°C. 
The measure of the diameter inhibition against microorganisms was undertaken by the discs method (25 µL 
extract by disc). Values represent diameter inhibition in mm, including the discs diameter (6 mm). 
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Figure 3. Choice of extraction solvent of antibiotic activities produced on PDB media by 
the Bacillus sp. strain B29. Values represent diameters of inhibition in mm (including the 
disc diameter that is 6 mm) against M. r. M. ramannianus; B. c. B. cinerea; S. c. S. 
cerevisiae; P. a. P. aeruginosa and M. l. M. luteus. 
 
 
 
This activity was not extracted by n-butanol or by the 
other organic solvents such as ethyl acetate, 
dichloromethane and n-hexane. 
 
 
Partial characterization of antifungal products of 
Bacillus B29 strain 
 
The cell-free supernatant of 1.5 L of liquid culture of B29 
strain was extracted by hexane. The organic phase was 
concentrated to dryness, recuperated in methanol and 
chromatographed by TLC. On analytic TLC plates deve-
loped in BAW solvent system, many active spots were 
detected by bioautography. Antifungal spots at 0.30 and 
0.76 Rf values and antibacterial spots at 0.12, 0.14, 0.19 
and 0.30 Rf values. The antibiotic localized at 0.30 Rf 
value showed strong antibacterial and antifungal 
activities.  
Antimicrobial activity guided fractionation of the broth of 
B29 culture showed that the hexane extract exhibited 
inhibitory activity against the filamentous fungi tested, 
and the butanol extract showed activity against the 
bacterial strains. Further fractionation of the hexane 
extract was undertaken by reverse phase HPLC. Figure 4 
shows a representative HPLC trace of hexane extract 
when separated on a C18 semi-preparative HPLC 
column and detected at 220 nm. Seventeen fractions 
could be clearly resolved under the conditions employed. 
Of the 17 fractions that were tested for antimicrobial 
activity, fractions 15 and 16 were found to be active 
against M. ramannianus and M. luteus. The remaining 
fractions did not exhibit antimicrobial activity. Antibiotic 15 
shown maxima, UV-VIS spectrum absorbance in 
methanol, at 210, 224 and 272 nm. Antibiotic 16 exhibited 
the most interesting activity. Its UV-VIS spectrum in 
methanol showed maxima at 203, 224 and 270 nm.  
 
 
Molecular identification and phylogenetic analysis of 
bacteria 
 
Data from the 16S rDNA gene provide a limited number 
of characters that are informative for the phylogeny of the 
Bacillus strain. Aspect of tree presented in Figures 5 and 
6 appears to be informative. Based on the sequence 
homology and phylogenic analysis, organism was found 
to be Bacillus (1104513.1). It is more closely related to 
Bacillus sp. Z19 (EU236746.1). For the Bacillus B29 
strain (1104513.2), it was found to be more closely 
related to Bacillus amyloliquefaciens strain EXWB3-03 
(EU334107.1). The partial sequence analysis of the 16S 
rDNA gene and BLAST sequence comparison in the 
GenBank database showed an alignment of 1414/1415 
bases (99% similarity) of the strain B27 (accession 
number 1104513.1) with the sequence of B. subtilis strain 
PCL 1605 (accession number DQ779882.1), similar 
results have been also obtained for B. mojavensis strain 
BCRC 17531 (accession number DQ993678.1). For the 
strain B29 (accession number 1104513.2), the 16S rDNA 
gene partial sequence aligned with the sequence of B. 
amyloliquefaciens strain TB2 (accession number 
EU359773.1), though at the lower similarity level of 99% 
with an alignment of 1414/1415 bases and with the B. 
subtilis strain Pab02 (accession number EU346662.1). 
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Figure 4. HPLC trace of hexane extract of the culture broth of Bacillus sp. strain B29. 
Seventeen fractions are of relatively high intensity, are easily identified. In addition 
several peaks of lower intensity are also observed. Majority of the observed 
antimicrobial activity appears to arise from compounds in peaks 15 and 16. 
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Figure 5. Phylogenetic tree derived from parsimony analysis of 16S rDNA gene from Bacillus sp. strain B27 (accession 
number 1104513.1). The 1415 bases determined for B27 were aligned to the corresponding regions from bacteria. The 
number at the nodes indicate the levels of bootstrap support based on neighbor-joining analyses of 1000 resampled 
data sets; only values over 50% are given. Bar, 0.0002 nt substitution per nt position. 
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Bacillus subtilis Pab02 
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Bacillus amyloliquefaciens BCRC141931 
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Figure 6. Phylogenetic tree derived from parsimony analysis of 16S rDNA gene from Bacillus sp. strain B29 (accession 
number 1104513.2). The 1415 bases determined for B29 were aligned to the corresponding regions from bacteria. The 
number at the nodes indicate the levels of bootstrap support based on neighbor-joining analyses of 1000 resampled data 
sets; only values over 50% are given. Bar, 0.0005 nt substitution per nt position. 
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DISCUSSION 
 
Microorganisms produce some of the most important 
compounds with pesticidal activity. They are the source 
of lifesaving treatments for bacterial and fungal infections. 
In spite of the tremendous success of the past secondary 
metabolite research, the number of terrestrial antibiotics 
seems currently to approach a saturation curve with an 
apparent limit in the near future. The increasing number 
of duplications and the urgent demand for few leading 
structures in pharmacology and agriculture, have 
enforced the search for metabolites in so far untouched 
habitats. Our interest focused on microorganisms 
belonging to the Bacillus genus, the members of which 
have demonstrated interesting antimicrobial activity. In 
this article, we have described the use of Bacillus strains 
B27 and B29 isolated from salt soil as well as their 
secreted secondary metabolites to act as antimicrobial 
product against a large range of microorganisms tested 
(bacteria, yeasts and filamentous fungi). Cho et al. (2009) 
have recently described the use of many strains of 
Bacillus sp. as antifungal and antibiotic agents.  
The extent of the antibiosis of the two Bacillus isolates 
against the test organisms, evaluated in terms of reduced 
radial growth, is almost similar. The two isolates exhibited 
a strong activity (inhibition zone > 20 mm) against Gram-
positive and Gram-negative bacteria, yeast and filament-
tous fungi. The strong activity expressed by a large zone 
of inhibition on agar plates indicated, as mentioned by 
Barakate et al. (2002), that those two isolates produce 
water soluble antimicrobial metabolites which may play 
an important role in the biocontrol of plant diseases. 
Results of antibiotics activity expressed in terms of the 
diameter of the inhibition zone showed differences in the 
percentage of antibiosis and specificity of efficacy; this 
may imply that the two investigated Bacillus isolates 
belong to different species or to the same one but they 
produced different bioactive compounds exhibiting inhibi-
tory activity against a large number of microorganisms.  
These results were confirmed by the time course of 
growth and antibiotics production of the two strains. In 
fact, we noted many differences that concerned the 
specificity of the antibiotics and their time of production. 
The chemical nature of the compounds responsible for 
the observed activity in the organic solvent extracts, 
respectively for B29 and B27 strains, are being 
elucidated. The Bacillus species are widely recognized as 
a rich source of antimicrobial agents (Gebhardt et al., 
2002). Many antibiotics including cyclic peptides, cyclic 
lipopeptides and novel thiopeptides have been reported 
from Bacillus sp. (Nagai et al., 2003).  
The bioautography of the hexane extract of the B29 
strain has revealed several products active against 
bacteria and fungus suggesting the presence of 
antibiotics having probably different chemical structures. 
The B29 strain active fractions 15 and 16 have a time of 
retention of  47.5  and  48.35 min  respectively.  The  UV-  
 
 
 
visible spectra in methanol of these two fractions  
exhibited maxima at 270 nm suggesting the presence of 
an aromatic ring compound (Badji et al., 2005; Zitouni et 
al., 2005). The 16S rDNA gene sequence analysis has 
been described to be necessary mainly to detect some 
misidentification of Bacillus and related strains 
(Guinebretiere et al., 2001; Wu et al., 2006). Sequencing 
the nucleotide positions 70 to 344 of the 50 end region of 
the 16S rDNA gene may represent a very efficient index 
for the identification of Bacillus and Paenibacillus species 
being this region the most informative one. In fact, about 
275 pb of the 50 end region of the 16S rDNA gene were 
the hypervariant region in the gene and it was highly 
specific for each Bacillus type strain, but also highly 
conserved within the species (Goto et al., 2000). The 16S 
rDNA sequence of B27 and B29 strains were compared 
with those of other Bacillus species. The similarity level 
was about 99% with B. subtilis and B. mojavensis for the 
B27 strain and was about 99% with B. amyloliquefaciens 
and B. subtilis for the B29 strain. However, it is clear from 
phylogenetic analysis that these two strains did not 
cluster with neither B. subtilis, nor B. amyloliquefaciens 
nor B. mojavensis and represented distinct phyletic lines 
suggesting new genomic species. All results suggest that 
both strains may be new species of Bacillus. The 
antifungal activities exhibited especially against B. 
cinerea showed that both strains may play an important 
role in biological control. Further studies are needed to 
determine the ability of these strains to control disease 
caused by B. cinerea on Vitis vinifera.  
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